AI assistant
Sending…
CLOROX CO /DE/ — Director's Dealing 2022
Sep 22, 2022
30403_dirs_2022-09-22_fdc3ff6d-2c97-4afe-a6b9-18acf73a21a9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CLOROX CO /DE/ (CLX)
CIK: 0000021076
Period of Report: 2022-09-20
Reporting Person: Rendle Linda J (Director, Chief Executive Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-09-20 | Common Stock | A | 9907.0000 | $141.3000 | Acquired | 42584.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-09-20 | Stock Option (Right to Buy) | $141.3000 | A | 51928.0000 | Acquired | 2032-09-20 | Common Stock (51928.0000) | Direct |
Footnotes
F1: The Restricted Stock Units will vest in 4 equal installments - 1/4 on each of October 5, 2023, 2024, 2025 and 2026.
F2: Includes 34 shares acquired pursuant to a dividend reinvestment feature of the Company's Stock Incentive Plan.
F3: Option vests in 4 equal installments - 1/4 on each of October 5, 2023, 2024, 2025 and 2026.
More from CLOROX CO /DE/
Regulatory Filings
2026
Jun 1
Board/Management Information
2026
May 28
Capital/Financing Update
2026
May 11
Regulatory Filings
2026
May 8
Capital/Financing Update
2026
May 6
Capital/Financing Update
2026
May 6
Capital/Financing Update
2026
May 1
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Major Shareholding Notification
2026
Apr 29